Labor Induction in Women with Isolated Polyhydramnios at Term: A Multicenter Retrospective Cohort Analysis
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Population and Period
2.3. Inclusion and Exclusion Criteria
2.4. Comparison Groups
2.5. Definitions
2.6. Outcomes Measures
2.7. Ethical Considerations
2.8. Statistical Methods
3. Results
4. Discussion
Strengths and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Dashe, J.S.; Pressman, E.K.; Hibbard, J.U. SMFM Consult Series #46: Evaluation and management of polyhydramnios. Am. J. Obstet. Gynecol. 2018, 219, B2–B8. [Google Scholar] [CrossRef]
- Hamza, A.; Herr, D.; Solomayer, E.F.; Meyberg-Solomayer, G. Polyhydramnios: Causes, Diagnosis and Therapy. Geburtshilfe Frauenheilkd. 2013, 73, 1241–1246. [Google Scholar] [CrossRef]
- Magann, E.F.; Chauhan, S.P.; Doherty, D.A.; Lutgendorf, M.A.; Magann, M.I.; Morrison, J.C. A review of idiopathic hydramnios and pregnancy outcomes. Obstet. Gynecol. Surv. 2007, 62, 795–802. [Google Scholar] [CrossRef]
- Hill, L.M.; Breckle, R.; Thomas, M.L.; Fries, J.K. Polyhydramnios: Ultrasonically detected prevalence and neonatal outcome. Obstet. Gynecol. 1987, 69, 21–25. [Google Scholar]
- Aviram, A.; Salzer, L.; Hiersch, L.; Ashwal, E.; Golan, G.; Pardo, J.; Wiznitzer, A.; Yogev, Y. Association of isolated polyhydramnios at or beyond 34 weeks of gestation and pregnancy outcome. Obstet. Gynecol. 2015, 125, 825–832. [Google Scholar] [CrossRef] [PubMed]
- Abele, H.; Starz, S.; Hoopmann, M.; Yazdi, B.; Rall, K.; Kagan, K.O. Idiopathic polyhydramnios and postnatal abnormalities. Fetal Diagn. Ther. 2012, 32, 251–255. [Google Scholar] [CrossRef] [PubMed]
- Karahanoglu, E.; Ozdemirci, S.; Esinler, D.; Fadıloglu, E.; Asiltürk, S.; Kasapoglu, T.; Yalvac, E.S.; Kandemir, N.O. Intrapartum, postpartum characteristics and early neonatal outcomes of idiopathic polyhydramnios. J. Obstet. Gynaecol. 2016, 36, 710–714. [Google Scholar] [CrossRef] [PubMed]
- Khazaei, S.; Jenabi, E. The association between polyhydramnios and the risk of placenta abruption: A meta-analysis. J. Matern. Neonatal Med. 2020, 33, 3035–3040. [Google Scholar] [CrossRef] [PubMed]
- Zeino, S.; Carbillon, L.; Pharisien, I.; Tigaizin, A.; Benchimol, M.; Murtada, R.; Boujenah, J. Delivery outcomes of term pregnancy complicated by idiopathic polyhydramnios. J. Gynecol. Obstet. Hum. Reprod. 2017, 46, 349–354. [Google Scholar] [CrossRef]
- Polnaszek, B.; Liang, B.; Zhang, F.; Cahill, A.G.; Raghuraman, N.; Young, O.M. Idiopathic Polyhydramnios and Neonatal Morbidity at Term. Am. J. Perinatol. 2021, 40, 1827–1833. [Google Scholar] [CrossRef]
- Bas Lando, M.; Urman, M.; Weiss, Y.; Srebnik, N.; Grisaru-Granovsky, S.; Farkash, R.; Sela, H.Y. Term Idiopathic Polyhydramnios, and Labor Complications. J. Clin. Med. 2023, 12, 981. [Google Scholar] [CrossRef]
- Pilliod, R.A.; Page, J.M.; Burwick, R.M.; Kaimal, A.J.; Cheng, Y.W.; Caughey, A.B. The risk of fetal death in nonanomalous pregnancies affected by polyhydramnios. Am. J. Obstet. Gynecol. 2015, 213, 410.e1–410.e6. [Google Scholar] [CrossRef]
- ACOG Committee Opinion. Medically Indicated Late-Preterm and Early-Term Deliveries: ACOG Committee Opinion, Number 831. Obstet. Gynecol. 2021, 138, e35–e39. [Google Scholar] [CrossRef] [PubMed]
- Grobman, W.A.; Rice, M.M.; Reddy, U.M.; Tita, A.T.N.; Silver, R.M.; Mallett, G.; Hill, K.; Thom, E.A.; El-Sayed, Y.Y.; Perez-Delboy, A.; et al. Labor Induction versus Expectant Management in Low-Risk Nulliparous Women. N. Engl. J. Med. 2018, 379, 513–523. [Google Scholar] [CrossRef] [PubMed]
- ACOG Clinical Guidance for Integration of the Findings of The ARRIVE Trial: Labor Induction Versus Expectant Management in Low-Risk Nulliparous Women n.d. Available online: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2018/08/clinical-guidance-for-integration-of-the-findings-of-the-arrive-trial (accessed on 21 February 2024).
- SMFM Statement on Elective Induction of Labor in Low-Risk Nulliparous Women at Term: The ARRIVE Trial. Am. J. Obstet. Gynecol. 2019, 221, B2–B4. [CrossRef] [PubMed]
- Middleton, P.; Shepherd, E.; Crowther, C.A. Induction of labour for improving birth outcomes for women at or beyond term. Cochrane Database Syst. Rev. 2018, 2018, CD004945. [Google Scholar] [CrossRef]
- NICE Inducing Labour Guidance. NICE. 2021. Available online: https://www.nice.org.uk/guidance/ng207/resources/inducing-labour-pdf-66143719773637 (accessed on 21 February 2024).
- Carmichael, S.L.; Snowden, J.M. The ARRIVE Trial: Interpretation from an Epidemiologic Perspective. J. Midwifery Womens Health 2019, 64, 657–663. [Google Scholar] [CrossRef]
- Swift, E.M.; Gunnarsdottir, J.; Zoega, H.; Bjarnadottir, R.I.; Steingrimsdottir, T.; Einarsdottir, K. Trends in labor induction indications: A 20-year population-based study. Acta Obstet. Gynecol. Scand. 2022, 101, 1422–1430. [Google Scholar] [CrossRef] [PubMed]
- Sinkey, R.G.; Blanchard, C.T.; Szychowski, J.M.; Ausbeck, E.; Subramaniam, A.; Neely, C.L.; Casey, B.M.; Tita, A.T. Elective Induction of Labor in the 39th Week of Gestation Compared with Expectant Management of Low-Risk Multiparous Women. Obstet. Gynecol. 2019, 134, 282–287. [Google Scholar] [CrossRef] [PubMed]
- Fonseca, M.J.; Santos, F.; Afreixo, V.; Silva, I.S.; Almeida, M.D.C. Does induction of labor at term increase the risk of cesarean section in advanced maternal age? A systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020, 253, 213–219. [Google Scholar] [CrossRef]
- Vanda, R.; Bazrafkan, M.; Rouhani, M.; Bazarganipour, F. Comparing pregnancy, childbirth, and neonatal outcomes in women with idiopathic polyhydramnios: A prospective cohort study. BMC Pregnancy Childbirth 2022, 22, 399. [Google Scholar] [CrossRef]
- James-Conterelli, S.; Kennedy, H.P. Does the ARRIVE trial merit changing obstetric practice? Some reflections four-year postrelease. Birth 2023, 50, 258–266. [Google Scholar] [CrossRef]
- Little, S.E. Elective Induction of Labor: What is the Impact? Obstet. Gynecol. Clin. N. Am. 2017, 44, 601–614. [Google Scholar] [CrossRef]
- Saccone, G.; Della Corte, L.; Maruotti, G.M.; Quist-Nelson, J.; Raffone, A.; De Vivo, V.; Esposito, G.; Zullo, F.; Berghella, V. Induction of labor at full-term in pregnant women with uncomplicated singleton pregnancy: A systematic review and meta-analysis of randomized trials. Acta Obstet. Gynecol. Scand. 2019, 98, 958–966. [Google Scholar] [CrossRef]
- Wennerholm, U.-B.; Saltvedt, S.; Wessberg, A.; Alkmark, M.; Bergh, C.; Wendel, S.B.; Fadl, H.; Jonsson, M.; Ladfors, L.; Sengpiel, V.; et al. Induction of labour at 41 weeks versus expectant management and induction of labour at 42 weeks (SWEdish Post-term Induction Study, SWEPIS): Multicentre, open label, randomised, superiority trial. BMJ 2019, 367, l6131. [Google Scholar] [CrossRef]
- Matěcha, J.; Nováčková, M. Idiopathic polyhydramnios. Ces Gynekol. 2020, 85, 417–421. [Google Scholar]
- Backley, S.; Orr, L.; Knee, A.; Schoen, C. Induction of Labor Versus Expectant Management in Patients With Non-anomalous Idiopathic Polyhydramnios [16E]. Obstet. Gynecol. 2019, 133, 55S. [Google Scholar] [CrossRef]
- Sohaey, R.; Nyberg, D.A.; Sickler, G.K.; Williams, M.A. Idiopathic polyhydramnios: Association with fetal macrosomia. Radiology 1994, 190, 393–396. [Google Scholar] [CrossRef] [PubMed]
- Pagan, M.; Magann, E.F.; Rabie, N.; Steelman, S.C.; Hu, Z.; Ounpraseuth, S. Idiopathic polyhydramnios and pregnancy outcome: Systematic review and meta-analysis. Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol. 2023, 61, 302–309. [Google Scholar] [CrossRef] [PubMed]
- Cauldwell, M.; Chmielewska, B.; Kaur, K.; van-de-l’Isle, Y.; Sherry, A.; Watt Coote, I.; Steer, P.J. Screening for late-onset gestational diabetes: Are there any clinical benefits? BJOG 2022, 129, 2176–2183. [Google Scholar] [CrossRef] [PubMed]
- Lan, L.-B.; Li, D.-Z. Idiopathic polyhydramnios and foetal macrosomia in the absence of maternal diabetes: Clinical vigilance for costello syndrome. J. Obstet. Gynaecol. J. Inst. Obstet. Gynaecol. 2022, 42, 704–706. [Google Scholar] [CrossRef] [PubMed]
Normal Amount of Amniotic Fluid n = 842 | Polyhydramnios n = 162 | p Value | |
---|---|---|---|
Maternal age, years | 30.1 ± 6.2 | 30 ± 6.4 | 0.90 |
Miscarriages, any | 277 (32.9%) | 63 (36.2%) | 0.39 |
Miscarriages ≥ 3 | 49 (5.8%) | 14 (8%) | 0.27 |
Gravidity | 4 [2–6] | 4 [2–7] | 0.11 |
Parity | 3 [1–5] | 3 [2–6] | 0.10 |
Primiparity | 232 (27.5%) | 41 (23.6%) | 0.28 |
Fertility Treatments | 50 (5.9%) | 12 (6.9%) | 0.63 |
Hypertensive disorders of pregnancy | 5 (0.6%) | 1 (0.6%) | 0.98 |
Smoking | 16 (2.1%) | 3 (1.8%) | 0.85 |
Obesity (BMI ≥ 30) | 140 (21%) | 43 (32.3%) | <0.01 |
Anemia, Hb < 11 g/dL on admission | 109 (12.9%) | 30 (17.2%) | 0.13 |
Cervical dilation on admission | 2 [1–3] | 2 [1–3] | 0.09 |
Cervical ripening | 260 (32.4%) | 40 (25.5%) | 0.09 |
Meconium-stained amniotic fluid | 136 (16.1%) | 31 (17.8%) | 0.59 |
Epidural analgesia | 732 (86.8%) | 152 (87.4%) | 0.85 |
Persistent Occipito-Posterior | 21 (3.5%) | 7 (5.8%) | 0.22 |
Gestational age at delivery | 40.5 ± 0.5 | 40.4 ± 0.5 | <0.01 |
Normal Amount of Amniotic Fluid n = 842 | Polyhydramnios n = 162 | p Value | |
---|---|---|---|
Primary outcome | |||
Composite adverse maternal outcome * | 172 (20.4%) | 50 (28.7%) | 0.02 |
Components of the primary outcome | |||
Unplanned cesarean | 79 (9.4%) | 19 (10.9%) | 0.53 |
Postpartum hemorrhage | 93 (11%) | 29 (16.7%) | 0.04 |
Blood products transfusion | 7 (0.8%) | 4 (2.3%) | 0.09 |
Chorioamnionitis | 45 (5.3%) | 5 (2.9%) | 0.17 |
Perineal tear grade 3/4 | 3 (0.4%) | 3 (1.7%) | 0.03 |
Uterine rupture | 0 (0%) | 1 (0.6%) | 0.03 |
Hysterectomy | 0 (0%) | 0 (0%) | N/A |
Laparotomy | 0 (0%) | 1 (0.6%) | 0.03 |
Puerperal fever | 34 (4%) | 4 (2.3%) | 0.27 |
Maternal ICU admissions | 0 (0%) | 0 (0%) | N/A |
Prolonged hospital stays | 22 (2.6%) | 10 (5.7%) | 0.03 |
Other outcomes | |||
Gestational age at delivery > 41 week | 269 (31.9%) | 49 (28.2%) | 0.33 |
First stage duration, minutes | 555.4 ± 382.2 | 591.7 ± 430.5 | 0.31 |
Second stage duration, minutes | 39.9 ± 57.5 | 42.9 ± 62 | 0.56 |
Episiotomy | 106 (12.6%) | 18 (10.3%) | 0.41 |
Shoulder dystocia | 6 (0.7%) | 2 (1.1%) | 0.55 |
Retained placenta/placental fragments | 31 (3.8%) | 11 (6.5%) | 0.12 |
Hemoglobin drop, g/dL | 1.3 ± 1.1 | 1.5 ± 1.3 | 0.20 |
Hemoglobin drop > 4 g/dL | 33 (3.9%) | 12 (6.9%) | 0.08 |
Vacuum-assisted delivery | 83 (9.8%) | 19 (10.9%) | 0.67 |
Hospitalization length, days | 2.3 ± 1.3 | 2.8 ± 2.4 | <0.01 |
Normal Amount of Amniotic Fluid n = 842 | Polyhydramnios n = 162 | p Value | |
---|---|---|---|
Birthweight | 3594.1 ± 434.1 | 3788.6 ± 369.5 | <0.01 |
Birthweight ≥ 4000 g | 95 (11.3%) | 37 (21.3%) | <0.01 |
LGA | 143 (17%) | 59 (33.9%) | <0.01 |
Male sex | 428 (50.8%) | 108 (62.1%) | <0.01 |
1-Minute Apgar score < 7 | 30 (3.6%) | 6 (3.4%) | 0.94 |
5-Minute Apgar score < 7 | 6 (0.7%) | 2 (1.1%) | 0.55 |
Intrapartum Fetal Death | 0 (0%) | 1 (0.6%) | 0.03 |
NICU admission | 24 (2.8%) | 7 (4%) | 0.41 |
Meconium aspiration syndrome | 1 (0.1%) | 0 (0%) | 0.65 |
Jaundice | 49 (5.8%) | 8 (4.6%) | 0.52 |
TTN | 8 (1%) | 1 (0.6%) | 0.63 |
Mechanical ventilation | 13 (1.5%) | 2 (1.1%) | 0.69 |
Seizures | 11 (1.3%) | 6 (3.4%) | 0.05 |
Erb’s palsy/fracture of clavicle | 5 (0.6%) | 1 (0.6%) | 0.98 |
Hypoglycemia | 7 (0.8%) | 6 (3.4%) | <0.01 |
Sepsis | 3 (0.4%) | 0 (0%) | 0.43 |
Encephalopathy | 1 (0.1%) | 0 (0%) | 0.65 |
Intracranial hemorrhage | 4 (0.5%) | 0 (0%) | 0.36 |
Birth asphyxia | 4 (0.5%) | 2 (1.1%) | 0.29 |
p Value | aOR | 95%CI | ||
---|---|---|---|---|
Parity | <0.01 | 0.72 | 0.65 | 0.81 |
Polyhydramnios | <0.01 | 1.98 | 1.27 | 3.10 |
Epidural analgesia | 0.01 | 0.50 | 0.31 | 0.82 |
Maternal age, years | 0.01 | 1.05 | 1.01 | 1.08 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Lerner, Y.; Peled, T.; Yehushua, M.; Rotem, R.; Weiss, A.; Sela, H.Y.; Grisaru-Granovsky, S.; Rottenstreich, M. Labor Induction in Women with Isolated Polyhydramnios at Term: A Multicenter Retrospective Cohort Analysis. J. Clin. Med. 2024, 13, 1416. https://doi.org/10.3390/jcm13051416
Lerner Y, Peled T, Yehushua M, Rotem R, Weiss A, Sela HY, Grisaru-Granovsky S, Rottenstreich M. Labor Induction in Women with Isolated Polyhydramnios at Term: A Multicenter Retrospective Cohort Analysis. Journal of Clinical Medicine. 2024; 13(5):1416. https://doi.org/10.3390/jcm13051416
Chicago/Turabian StyleLerner, Yael, Tzuria Peled, Morag Yehushua, Reut Rotem, Ari Weiss, Hen Y. Sela, Sorina Grisaru-Granovsky, and Misgav Rottenstreich. 2024. "Labor Induction in Women with Isolated Polyhydramnios at Term: A Multicenter Retrospective Cohort Analysis" Journal of Clinical Medicine 13, no. 5: 1416. https://doi.org/10.3390/jcm13051416
APA StyleLerner, Y., Peled, T., Yehushua, M., Rotem, R., Weiss, A., Sela, H. Y., Grisaru-Granovsky, S., & Rottenstreich, M. (2024). Labor Induction in Women with Isolated Polyhydramnios at Term: A Multicenter Retrospective Cohort Analysis. Journal of Clinical Medicine, 13(5), 1416. https://doi.org/10.3390/jcm13051416